2020
DOI: 10.1007/s10198-020-01191-y
|View full text |Cite
|
Sign up to set email alerts
|

Cost-effectiveness of biennial screening for diabetes related retinopathy in people with type 1 and type 2 diabetes compared to annual screening

Abstract: Objective Examine the health and economic impact of extending screening intervals in people with Type 2 diabetes (T2DM) and Type 1 diabetes (T1DM) without diabetes-related retinopathy (DR). Setting Diabetic Eye Screening Wales (DESW). Study design Retrospective observational study with cost-utility analysis (CUA) and Decremental Cost-Effectiveness Ratios (DCER) study. Intervention Biennial screening versus usual care (annual screening). Inputs Anonymised data from DESW were linked to primary care data for peop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 33 publications
0
9
0
Order By: Relevance
“…This study presents critical insights into the implications of extending intervals for diabetic eye screening, especially among multiethnic populations 1. Research suggests extending screening intervals to biennial for low-risk patients may be cost-effective but calls for caution due to varying risk definitions and patient adherence 2. Additional findings highlight the importance of considering ethnic-specific prevalence and variations in visual impairment, suggesting significant roles of genetic, lifestyle and healthcare access differences in the progression of DR 3.…”
Section: Commentarymentioning
confidence: 90%
“…This study presents critical insights into the implications of extending intervals for diabetic eye screening, especially among multiethnic populations 1. Research suggests extending screening intervals to biennial for low-risk patients may be cost-effective but calls for caution due to varying risk definitions and patient adherence 2. Additional findings highlight the importance of considering ethnic-specific prevalence and variations in visual impairment, suggesting significant roles of genetic, lifestyle and healthcare access differences in the progression of DR 3.…”
Section: Commentarymentioning
confidence: 90%
“…Additionally, the data on detailed costs for AI screening conducted in rural China, especially indirect costs (i.e., the income loss of patients’ family associated with their blindness) and the compliance of screening and follow-up examination should be investigated. Moreover, screening intervals have been found to have influence on cost-effectiveness in many countries [ 43 47 ]. Since we used screening intervals recommended by ICO guidelines for diabetic eye care, individualized screening intervals suitable for Chinese patients should be investigated.…”
Section: Discussionmentioning
confidence: 99%
“…They estimated the cost to the Korean healthcare system at US$384,000 per 10,000 diabetics screened. Thomas et al described resource utilization of screening and the impact of DR treatment in Wales [ 22 ]. Derived from multiple sources, the data show that the cost of hospital-based screening was approximately one-tenth of the cost of surgical intervention (vitrectomy) and less than 2% of the cost of sight loss to a person living in a care home.…”
Section: Reviewmentioning
confidence: 99%